EDSA
Edesa Biotech IncNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$51.57M
P/E Ratio
—
EPS
$-1.31
Beta
1.07
52W High
$20.32
52W Low
$0.72
50-Day MA
$9.46
200-Day MA
$4.23
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
0.18
PEG Ratio
—
About Edesa Biotech Inc
Edesa Biotech, Inc., a clinical-stage biopharmaceutical company, is engaged in the research and development, manufacture and marketing of pharmaceuticals for inflammatory and immune-related diseases. The company is headquartered in Markham, Canada.
Fundamentals
| Revenue (TTM) | 500 |
| Gross Profit (TTM) | 311,200 |
| EBITDA | $-10.91M |
| Operating Margin | 0.00% |
| Return on Equity | -81.20% |
| Return on Assets | -47.70% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $0.20 |
| Price-to-Book | 28.31 |
| Price-to-Sales (TTM) | 130462.29 |
| EV/Revenue | 140491.25 |
| EV/EBITDA | -1.25 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | -99.90% |
| Shares Outstanding | $8.89M |
| Float | $5.54M |
| % Insiders | 18.87% |
| % Institutions | 36.48% |
Historical Volatility
HV 10-Day
—
HV 20-Day
—
HV 30-Day
—
HV 60-Day
—
HV Rank
—
Analyst Ratings
Consensus ($14.00 target)
2
BuyMore HEALTHCARE Stocks
Data last updated: 6/13/2026